Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bay State Culture Daily.
Press releases published on May 13, 2025

NordPass wins Global InfoSec Award for Passwordless Authenticator
LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- NordPass, the secure password manager developed by the cybersecurity experts behind NordVPN, has been named a winner at the Cyber Defense Magazine Global InfoSec Awards 2025, earning top recognition for its …

nextSource Celebrates the 2024 Keystone Recognition Program Winners
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- nextSource, a leader in strategic workforce transformation, proudly celebrated the winners of the 2024 nextSource Keystone Recognition Program at a special event held on May 8, 2025. This annual program honors …

Jellystone Park™ Camp-Resort Network Expands in U.S and Canada
SOUTHFIELD, Mich., May 13, 2025 (GLOBE NEWSWIRE) -- Yogi Bear’s Jellystone Park Camp-Resorts continues to expand across the U.S. and Canada, offering families both new locations as well as more attractions and more ways to stay at existing locations. “Our …

YMCA’s Summer Food Program Fights Hunger, Eases Financial Strain for Families Facing Rising Grocery Costs
CHICAGO, May 13, 2025 (GLOBE NEWSWIRE) -- The latest Household Food Security Report from the U.S. Department of Agriculture’s Economic Research Service confirms what anti-hunger advocates have warned: hunger in America is rising at alarming rates and has …

Pythian’s Vanessa Simmons and Donna Williston Again Named to CRN’s 2025 Women of the Channel List
OTTAWA, Ontario, May 13, 2025 (GLOBE NEWSWIRE) -- Pythian Services Inc. (“Pythian”), a leading global services company specializing in data, analytics, and AI solutions, is proud to announce today that CRN®, a brand of The Channel Company, has recognized …

General Oncology to Participate in Three Upcoming Conferences
BOSTON, May 13, 2025 (GLOBE NEWSWIRE) -- General Oncology, Inc., a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class treatments for metastatic cancers, today announced that members of its senior management team will …

IBN Initiates Coverage of Onar Holding Corporation
AUSTIN, Texas, May 13, 2025 (GLOBE NEWSWIRE) -- via IBN – Onar Holding Corporation (OTCQB: ONAR), a leading marketing technology company and agency network focused on integrated, AI-driven solutions to accelerate client revenue, has selected IBN, a …

Greif Receives Supplier Innovation Award from the U.S. Postal Service
DELAWARE, Ohio, May 13, 2025 (GLOBE NEWSWIRE) -- Greif (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, is proud to announce it has been awarded the Supplier Innovation Award by the United States Postal Service (USPS). The …

Vivid Seats Announces 2025 WNBA Loyalty Report
CHICAGO, May 13, 2025 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ: SEAT), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today …

Brunswick Corporation Releases 2024 Corporate Sustainability Report
METTAWA, Ill., May 13, 2025 (GLOBE NEWSWIRE) -- Brunswick Corporation (NYSE: BC) released its 2024 Sustainability Report today, highlighting the Company’s actions toward operating sustainably and delivering innovation and excellence in the marine industry. …

Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit
WATERTOWN, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …

Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
CAMBRIDGE, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, …

Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year® 2025 Mountain West Award Finalist
Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future KIRKLAND, Wash., May 13, 2025 (GLOBE NEWSWIRE) -- Ernst …

Highwire Appoints Powerhouse Michael O’Brien as CEO
SAN FRANCISCO, May 13, 2025 (GLOBE NEWSWIRE) -- Highwire, a strategic marketing communications agency partnering with brands at the intersection of innovation and industry, today announced the appointment of Michael O’Brien as its new chief executive …

Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference
WATERTOWN, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …

Command Alkon’s Batch AI Honored as a 2025 Concrete Contractor Top Products Award Winner
BIRMINGHAM, Ala., May 13, 2025 (GLOBE NEWSWIRE) -- Concrete Contractor, the nationally recognized magazine serving concrete construction professionals, names Command Alkon’s Batch AI a 2025 Concrete Contractor Top Products award winner. The 2025 Concrete …

Invivyd to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
WALTHAM, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that management will participate in a fireside chat at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on Tuesday, May 20, 2025, at 11:00 a.m. ET in …

Editas Medicine Reports New In Vivo Proof of Concept Data in an Undisclosed Liver Target at the American Society of Gene and Cell Therapy Annual Meeting
In vivo CRISPR Editing Results in Functional Upregulation of a Liver Target Protein and Meaningful Reduction of Disease-Associated Biomarker in Mice CAMBRIDGE, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene …

Beam Therapeutics to Participate in 2025 RBC Capital Markets Global Healthcare Conference
CAMBRIDGE, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in a fireside chat at the 2025 …

EyePoint Announces Participation at Upcoming Investor Conferences
WATERTOWN, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced …